Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative model-based analysis of screening programs for Chlamydia trachomatis infections.

M Kretzschmar1, R Welte, A van den Hoek

  • 1Department of Infectious Disease Epidemiology, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. mirjam.kretzschmar@rivm.nl

American Journal of Epidemiology
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating chikungunya outbreak size and emergency vaccination strategies in Miami: an exploratory modeling study.

BMC public health·2025
Same author

Hospital costs of different treatment strategies for anastomotic leakage after total mesorectal excision: a multicentre cost analysis.

Techniques in coloproctology·2025
Same author

Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus.

PharmacoEconomics - open·2024
Same author

Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality.

PharmacoEconomics - open·2023
Same author

Clinical pharmacy services for tuberculosis management: a systematic review.

Frontiers in pharmacology·2023
Same author

Implementing a Managed Entry Agreement Framework in Cyprus.

Expert review of pharmacoeconomics & outcomes research·2023

Targeted screening for Chlamydia trachomatis in young adults significantly reduces infection rates. Including partner referral enhances effectiveness and offers indirect benefits to unscreened populations.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Modeling

Background:

  • Asymptomatic genital infections with Chlamydia trachomatis pose a significant public health challenge.
  • Designing effective screening programs requires careful consideration of target demographics and intervention strategies like partner referral.

Purpose of the Study:

  • To evaluate the impact of different screening program designs on the prevalence and incidence of asymptomatic Chlamydia trachomatis infections in women.
  • To assess the role of partner referral in Chlamydia trachomatis control.

Main Methods:

  • Utilized a stochastic simulation model to simulate Chlamydia trachomatis transmission in an age-structured heterosexual population.
  • Implemented various screening scenarios over a 10-year period, targeting different age groups and incorporating partner referral.

Related Experiment Videos

Main Results:

  • Screening individuals aged 15-24 reduced female infection prevalence from 4.2% to 1.4% over 10 years.
  • Expanding screening to ages 29 or 34 further decreased prevalence to 0.4% and 0.06%, respectively.
  • Partner referral identified approximately 28% of infected individuals and contributed substantially to prevalence reduction.

Conclusions:

  • Broadening the age range for Chlamydia trachomatis screening demonstrably reduces infection prevalence in women.
  • Partner referral is a crucial component of screening programs, enhancing overall effectiveness and providing indirect population benefits.